Brainstorm Cell Therapeutics Inc (BCLI)
0.5209
-0.01
(-2.09%)
USD |
NASDAQ |
Apr 26, 16:00
0.5209
0.00 (0.00%)
After-Hours: 18:02
Brainstorm Cell Therapeutics Cash from Operations (Quarterly): -3.285M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.285M |
| September 30, 2023 | -6.409M |
| June 30, 2023 | -6.778M |
| March 31, 2023 | -3.986M |
| December 31, 2022 | -4.648M |
| September 30, 2022 | -4.85M |
| June 30, 2022 | -6.134M |
| March 31, 2022 | -3.688M |
| December 31, 2021 | -5.508M |
| September 30, 2021 | -6.46M |
| June 30, 2021 | -5.329M |
| March 31, 2021 | -8.968M |
| December 31, 2020 | -7.578M |
| September 30, 2020 | -6.924M |
| June 30, 2020 | -5.662M |
| March 31, 2020 | -15.03M |
| December 31, 2019 | -3.278M |
| September 30, 2019 | -3.626M |
| June 30, 2019 | -3.508M |
| March 31, 2019 | -0.835M |
| December 31, 2018 | -3.723M |
| September 30, 2018 | -6.594M |
| June 30, 2018 | 0.055M |
| March 31, 2018 | -2.126M |
| December 31, 2017 | -2.935M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.843M |
| June 30, 2017 | -1.63M |
| March 31, 2017 | -1.642M |
| December 31, 2016 | -1.196M |
| September 30, 2016 | -0.275M |
| June 30, 2016 | -1.406M |
| March 31, 2016 | -2.981M |
| December 31, 2015 | -1.291M |
| September 30, 2015 | -2.53M |
| June 30, 2015 | -1.65M |
| March 31, 2015 | -1.937M |
| December 31, 2014 | -2.007M |
| September 30, 2014 | -1.119M |
| June 30, 2014 | -0.97M |
| March 31, 2014 | -0.391M |
| December 31, 2013 | -1.608M |
| September 30, 2013 | -0.713M |
| June 30, 2013 | -1.063M |
| March 31, 2013 | -0.67M |
| December 31, 2012 | -0.696M |
| September 30, 2012 | -1.074M |
| June 30, 2012 | -0.419M |
| March 31, 2012 | -0.746M |
| December 31, 2011 | -0.471M |
| September 30, 2011 | -0.897M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-15.03M
Minimum
Mar 2020
-3.278M
Maximum
Dec 2019
-5.876M
Average
-5.508M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.196M |
| Cash from Financing (Quarterly) | 3.352M |
| Free Cash Flow | -20.48M |
| Free Cash Flow Per Share (Quarterly) | -0.0637 |
| Free Cash Flow Yield | -91.30% |